Related Experiment Video
Updated: Aug 12, 2025

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
CircCCDC66: Emerging roles and potential clinical values in malignant tumors
Xiaoxiao Wang1, Chao Zhang1, Huangqin Song1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Abstract:
Circular RNAs (circRNAs) are endogenous non-coding RNAs (ncRNAs) with a closed-loop structure. In recent years, circRNAs have become the focus of much research into RNA. CircCCDC66 has been identified as a novel oncogenic circRNA and is up-regulated in a variety of malignant tumors including thyroid cancer, non-small cell carcinoma, gastric cancer, colorectal cancer, renal cancer, cervical cancer, glioma, and osteosarcoma. It mediates cancer progression by regulating epigenetic modifications, variable splicing, transcription, and protein translation. The oncogenicity of circCCDC66 suppresses or promotes the expression of related genes mainly through direct or indirect pathways. This finding suggests that circCCDC66 is a biomarker for cancer diagnosis, prognosis assessment and treatment. However, there is no review on the relationship between circCCDC66 and cancers. Thus, the expression, biological functions, and regulatory mechanisms of circCCDC66 in malignant tumor and non-tumor diseases are summarized. The clinical value and prognostic significance of circCCDC66 are also evaluated, which can provide insights helpful to those exploring new strategies for the early diagnosis and targeted treatment of malignancies.
Insights
Circular RNAs (circRNAs) are novel oncogenic molecules found in many cancers. CircCCDC66 shows potential as a biomarker for cancer diagnosis, prognosis, and targeted therapies.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- Circular RNAs (circRNAs) are non-coding RNAs with a unique closed-loop structure.
- CircCCDC66 is identified as an oncogenic circRNA upregulated in various cancers.
- Its role in cancer progression via epigenetic modifications, splicing, transcription, and translation is increasingly recognized.
Purpose of the Study:
- To review the expression, biological functions, and regulatory mechanisms of circCCDC66 in malignant and non-tumor diseases.
- To evaluate the clinical value and prognostic significance of circCCDC66.
- To provide insights for developing new strategies for early cancer diagnosis and targeted treatment.
Main Methods:
- Literature review and synthesis of existing research on circCCDC66.
- Analysis of circCCDC66 expression patterns in various cancers.
- Evaluation of circCCDC66's functional roles and regulatory pathways in tumorigenesis.
Main Results:
- CircCCDC66 is upregulated in multiple cancers, including thyroid, gastric, and colorectal cancers.
- It influences cancer progression by modulating epigenetic modifications, splicing, transcription, and translation.
- CircCCDC66 acts as an oncogene, suppressing or promoting gene expression through direct/indirect pathways.
Conclusions:
- CircCCDC66 holds significant potential as a biomarker for cancer diagnosis, prognosis assessment, and treatment.
- Understanding circCCDC66's mechanisms offers new avenues for early cancer detection and targeted therapies.
- Further research into circCCDC66 is crucial for advancing oncology strategies.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

